AGs from 18 states offer solution to drug-import controversy

05/7/2004 | NYTimes.com

Eighteen attorneys general urged the federal government to allow the importation of U.S.-made drugs from Canada by licensing states to either act as wholesalers themselves or to contract with wholesalers for acquiring the drugs at lower costs than can be found in the United States. Under the plan, the FDA would approve the plants in which the drugs are made and the drugs would have to be shipped to the U.S. in their original packaging, a solution designed to satisfy pharmaceutical complaints about safety.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN